Fingerprint
Dive into the research topics of 'PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?
Elisena Franzese, Anna Diana, Sara Centonze, Sandro Pignata, Ferdinando De Vita, Fortunato Ciardiello, Michele Orditura
Research output: Contribution to journal › Review article › peer-review